Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Fed comments provide support ahead of BoE, ECB

Thu, 07th Mar 2013 08:43

The FTSE 100 held on to recent gains on Thursday morning ahead of central-bank policy decisions in the UK and Europe, as comments from the Federal Reserve provided some support.According to the Fed's Beige Book released last night, the US economy expanded at a "modest to moderate pace" at the start of 2013 due to strong car sales, hiring gains and a recovery in the housing sector.The UK benchmark index surged to levels not seen since late 2007 earlier this week a better-than-expected reading of US services activity and a pledge by China to hit its growth targets this year boosted markets.It appears that markets were pausing for breath today ahead of policy decisions from the Bank of England and European Central Bank expected after midday. Speculation has increased over the last month about changes to policy from both sides so investors are likely to sit on their hands and refrain from taking risk until someone makes a move.Overnight, the Bank of Japan voted to keep interest rates and its asset purchase programme unchanged, a decision that was widely expected given the Bank's recent aggressive easing.FTSE 100: Aviva plummets after 'rebasing' diviInsurance giant Aviva was forced to slash to dividend after swinging into the red in 2012, after taking a 3.3bn-pound write-down on a disposal in the US. Aviva also said that its overall situation does not warrant bonuses for executive directors for 2012 or pay rises for 2013. Shares dropped sharply early on.Heading the other way was temporary power and temperature control provider Aggreko after posting a strong performance with trading profit up 13% last year.Insurance provider Standard Life gained after unveiling a windfall dividend worth £302m after delivering substantial growth in profits in 2012 underpinned by strong performance in the UK.British asset management firm Schroders was higher after saying that assets under management (AuM) reached record levels in spite of choppy markets and falling profits.Pharma giant GlaxoSmithKline rose after announcing positive data from a drug study through ViiV Healthcare, a global specialist HIV company set up by GSK in 2009.FTSE 250: National Express dropsTransport group National Express was a heavy faller after reports yesterday said that US investor Elliot Advisors plans to sell over 50m worth of shares, equal to a 9.9% stake.Engineering firm Spirax-Sarco was in demand after proposing a special dividend of 100p per share in addition to an 8.0% rise in the full-year payout, after a 2.0% rise in revenue in 2012.FTSE 100 - RisersAggreko (AGK) 1,932.00p +9.90%IMI (IMI) 1,328.00p +5.23%Admiral Group (ADM) 1,362.00p +2.10%Standard Life (SL.) 380.30p +1.63%Unilever (ULVR) 2,721.00p +1.45%Barclays (BARC) 306.50p +1.44%Reckitt Benckiser Group (RB.) 4,568.00p +1.15%Antofagasta (ANTO) 1,075.00p +1.03%Kazakhmys (KAZ) 560.50p +0.99%Schroders (SDR) 2,056.00p +0.98%FTSE 100 - FallersAviva (AV.) 310.80p -13.62%Melrose Industries (MRO) 260.10p -2.62%Polymetal International (POLY) 958.00p -1.79%British Sky Broadcasting Group (BSY) 874.00p -1.63%Morrison (Wm) Supermarkets (MRW) 259.20p -1.52%Lloyds Banking Group (LLOY) 50.30p -1.41%Serco Group (SRP) 621.50p -0.88%Vodafone Group (VOD) 178.60p -0.78%Legal & General Group (LGEN) 164.90p -0.66%Old Mutual (OML) 208.80p -0.62%FTSE 250 - RisersRegus (RGU) 149.50p +4.18%Spirax-Sarco Engineering (SPX) 2,578.00p +3.00%RIT Capital Partners (RCP) 1,202.00p +2.56%SEGRO (SGRO) 264.60p +2.44%Cobham (COB) 234.20p +2.18%Betfair Group (BET) 702.00p +2.03%Jupiter Fund Management (JUP) 344.60p +1.83%Ashtead Group (AHT) 585.00p +1.74%Rotork (ROR) 2,951.00p +1.58%SIG (SHI) 142.50p +1.50%FTSE 250 - FallersNational Express Group (NEX) 206.90p -10.04%Petropavlovsk (POG) 257.10p -6.34%Hunting (HTG) 889.50p -4.51%Inmarsat (ISAT) 636.50p -4.36%IP Group (IPO) 135.00p -3.23%Balfour Beatty (BBY) 279.30p -2.68%Heritage Oil (HOIL) 192.50p -2.19%International Personal Finance (IPF) 463.90p -2.01%African Barrick Gold (ABG) 241.10p -1.87%Rank Group (RNK) 163.00p -1.69%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.